Bishal Adhikari is currently a PhD candidate at the School of Pharmacy, University of Otago, New Zealand. His work relates to the use of amino acids in conjunction with co-amorphization technique to improve aerosolization and chemical stability of inhalable high-dose amorphous antibiotic dry powders.
He completed his undergraduate in pharmacy from the Institute of Medicine, Tribhuvan University, Nepal, and a master's in industrial pharmacy from the School of Pharmacy, Korea University, South Korea before joining the PhD program at the University of Otago in 2018.

